BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17533051)

  • 1. CD34 human hematopoietic progenitor cell line, MUTZ-3, differentiates into functional osteoclasts.
    Ciraci E; Barisani D; Parafioriti A; Formisano G; Arancia G; Bottazzo G; Berardi AC
    Exp Hematol; 2007 Jun; 35(6):967-77. PubMed ID: 17533051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RANK Expression as a cell surface marker of human osteoclast precursors in peripheral blood, bone marrow, and giant cell tumors of bone.
    Atkins GJ; Kostakis P; Vincent C; Farrugia AN; Houchins JP; Findlay DM; Evdokiou A; Zannettino AC
    J Bone Miner Res; 2006 Sep; 21(9):1339-49. PubMed ID: 16939392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts.
    Kindle L; Rothe L; Kriss M; Osdoby P; Collin-Osdoby P
    J Bone Miner Res; 2006 Feb; 21(2):193-206. PubMed ID: 16418775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a novel bipotent hematopoietic progenitor population in normal and osteopetrotic mice.
    Blin-Wakkach C; Wakkach A; Rochet N; Carle GF
    J Bone Miner Res; 2004 Jul; 19(7):1137-43. PubMed ID: 15176997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts.
    Takeshita S; Kaji K; Kudo A
    J Bone Miner Res; 2000 Aug; 15(8):1477-88. PubMed ID: 10934646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c-kit+, CD34+, Ly-, CD14-, CD17-, colony-forming cell.
    Agis H; Willheim M; Sperr WR; Wilfing A; Krömer E; Kabrna E; Spanblöchl E; Strobl H; Geissler K; Spittler A; Boltz-Nitulescu G; Majdic O; Lechner K; Valent P
    J Immunol; 1993 Oct; 151(8):4221-7. PubMed ID: 7691941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of myeloid-associated genes in human hematopoietic progenitor cells.
    Bello-Fernández C; Matyash M; Strobl H; Scheinecker C; Knapp W
    Exp Hematol; 1997 Oct; 25(11):1158-66. PubMed ID: 9328452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of calcitonin on the function of human osteoclast-like cells formed from CD14-positive monocytes.
    Yamamoto Y; Yamamoto Y; Udagawa N; Okumura S; Mizoguchi T; Take I; Yamauchi H; Yamauchi H; Noguchi T; Takahashi N
    Cell Mol Biol (Noisy-le-grand); 2006 May; 52(3):25-31. PubMed ID: 17535751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between differentiation plasticity and mRNA expression profiling of CD34+-derived CD14- and CD14+ human normal myeloid precursors.
    Montanari M; Gemelli C; Tenedini E; Zanocco Marani T; Vignudelli T; Siena M; Zini R; Salati S; Chiossi G; Tagliafico E; Manfredini R; Grande A; Ferrari S
    Cell Death Differ; 2005 Dec; 12(12):1588-600. PubMed ID: 15947790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nurse-like cells from patients with rheumatoid arthritis support the survival of osteoclast precursors via macrophage colony-stimulating factor production.
    Tsuboi H; Udagawa N; Hashimoto J; Yoshikawa H; Takahashi N; Ochi T
    Arthritis Rheum; 2005 Dec; 52(12):3819-28. PubMed ID: 16320327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A CD34(+) human cell line model of myeloid dendritic cell differentiation: evidence for a CD14(+)CD11b(+) Langerhans cell precursor.
    Santegoets SJ; Masterson AJ; van der Sluis PC; Lougheed SM; Fluitsma DM; van den Eertwegh AJ; Pinedo HM; Scheper RJ; de Gruijl TD
    J Leukoc Biol; 2006 Dec; 80(6):1337-44. PubMed ID: 16959899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MUTZ-3-derived dendritic cells as an in vitro alternative model to CD34+ progenitor-derived dendritic cells for testing of chemical sensitizers.
    Nelissen I; Selderslaghs I; Heuvel RV; Witters H; Verheyen GR; Schoeters G
    Toxicol In Vitro; 2009 Dec; 23(8):1477-81. PubMed ID: 19732821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The generation and properties of human macrophage populations from hemopoietic stem cells.
    Way KJ; Dinh H; Keene MR; White KE; Clanchy FI; Lusby P; Roiniotis J; Cook AD; Cassady AI; Curtis DJ; Hamilton JA
    J Leukoc Biol; 2009 May; 85(5):766-78. PubMed ID: 19181863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G-CSF-mobilized CD34+ cells cultured in interleukin-2 and stem cell factor generate a phenotypically novel monocyte.
    Sconocchia G; Fujiwara H; Rezvani K; Keyvanfar K; El Ouriaghli F; Grube M; Melenhorst J; Hensel N; Barrett AJ
    J Leukoc Biol; 2004 Dec; 76(6):1214-9. PubMed ID: 15345723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
    Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R
    Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cord blood monocytes undergo terminal osteoclast differentiation in vitro in the presence of culture medium conditioned by giant cell tumor of bone.
    Roux S; Quinn J; Pichaud F; Orcel P; Chastre E; Jullienne A; De Vernejoul MC
    J Cell Physiol; 1996 Sep; 168(3):489-98. PubMed ID: 8816903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lineage commitment of CD34+ human hematopoietic progenitor cells.
    Tjønnfjord GE; Steen R; Veiby OP; Egeland T
    Exp Hematol; 1996 Jul; 24(8):875-82. PubMed ID: 8690045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of circulating human osteoclast progenitors: development of in vitro resorption assay.
    Husheem M; Nyman JK; Vääräniemi J; Vaananen HK; Hentunen TA
    Calcif Tissue Int; 2005 Mar; 76(3):222-30. PubMed ID: 15692727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment and characterization of new osteoclast progenitor cell lines derived from osteopetrotic and wild type mice.
    Blin-Wakkach C; Breuil V; Quincey D; Bagnis C; Carle GF
    Bone; 2006 Jul; 39(1):53-60. PubMed ID: 16503212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoclast culture and resorption assays.
    Bradley EW; Oursler MJ
    Methods Mol Biol; 2008; 455():19-35. PubMed ID: 18463808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.